Short dual antiplatelet therapy duration after percutaneous coronary intervention in high bleeding risk patients: Systematic review and meta-analysis

Dual antiplatelet therapy (DAPT) following percutaneous coronary intervention (PCI) reduces major adverse cardiovascular events (MACE) and stent thrombosis. However, DAPT duration is a concern in high bleeding risk (HBR) patients. We evaluated the effect of short DAPT (1-3 months) compared to standa...

Celý popis

Uloženo v:

Podrobná bibliografie
Vydáno v:	PloS one Ročník 18; číslo 9; s. e0291061
Hlavní autoři:	Bainey, Kevin R., Marquis-Gravel, Guillaume, MacDonald, Blair J., Bewick, David, Yan, Andrew, Turgeon, Ricky D.
Médium:	Journal Article
Jazyk:	angličtina
Vydáno:	San Francisco Public Library of Science 01.09.2023 Public Library of Science (PLoS)
Témata:	Acute coronary syndromes Aggregation Angioplasty Anticoagulants Antiplatelet therapy Bias Bleeding Blood clot Blood platelets Cardiovascular diseases Care and treatment Clinical trials Confidence intervals Consortia Health risks Heart attacks Implants Intervention Ischemia Medicine and Health Sciences Meta-analysis Mortality Patient outcomes Physical Sciences Prevention Research and Analysis Methods Risk assessment Stents Systematic review Thromboembolism Thrombosis Canada
ISSN:	1932-6203, 1932-6203
On-line přístup:	Získat plný text
Tagy:	Přidat tag Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!

Buďte první, kdo okomentuje tento záznam!